相关实验视频
Updated: Jun 16, 2025

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
解读泌尿癌中的分子通路:通往精密治疗的门户
Kiavash Hushmandi1, Najma Farahani2, Behzad Einollahi1
1Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
针对性疗法在泌尿癌中表现有前途,通过抑制PI3K/Akt和mTOR等关键信号通路. 进一步的研究可以提高治疗疗效和患者存活率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 泌尿系统癌症,包括前列腺癌,癌和膀癌,存在重大挑战,特别是在转移阶段.
- 虽然手术至关重要,但化疗,免疫疗法和向疗法的进步正在改善患者的治疗结果.
研究的目的:
- 本综述探讨了泌尿癌的向治疗方法.
- 它专注于像PI3K/Akt,mTOR,c-Met/HGF,PD-1/PD-L1这样的信号通路,以及瘤进展和抵抗中的类固醇激素受体.
主要方法:
- 对针对性疗法和尿道癌症信号通路的当前文献的审查.
- 分析特定途径 (PI3K/Akt,mTOR等) 的作用. 在瘤形成和治疗耐药性方面.
主要成果:
- 对PI3K/Akt和mTOR通路的调节失调有助于癌症生长和治疗耐药性.
- 氨酸激酶抑制剂和免疫检查点抑制剂显示出有效性,但面临着耐药性和毒性等挑战.
结论:
- 了解信号通路对于开发有效的向治疗至关重要.
- 将途径研究与临床实践相结合,可以提高泌尿癌的治疗疗效和患者存活率.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...